Literature DB >> 7137868

Electrophoretically determined haemoglobin A1 concentrations during short-term changes in glucose concentration.

R Puukka, M Leppilampi.   

Abstract

In our experience, electrophoresis on agar gel is a very satisfactory alternative to the more widely used chromatographic methods for the determination of haemoglobin A1 (HbA1). Like the chromatographic method, the electrophoretic method is unable to detect any difference between the labile intermediate form of HbA1, which changes rapidly with acute changes in blood glucose level, and the more stable end-product, which reflects long-term glucose levels. In vitro at 37 degrees C the electrophoretically determined HbA1 concentration increases with increasing glucose concentration and with time in both normal and diabetic erythrocytes, but decreases to the preincubation concentration during further incubation of the erythrocytes in a glucose-free medium at 37 degrees C. Similarly, if normal or diabetic erythrocytes are incubated with isotonic saline before the HbA1 assay, the labile fraction is eliminated. In diabetics, the decrease in HbA1 concentration correlates with both the blood glucose level and the preincubation HbA1 concentration. Thus for HbA1 to be an accurate indicator of long-term glucose control in diabetic patients saline incubation of the erythrocytes may be necessary before HbA1 assay by the electrophoretic method, otherwise the assay results will also reflect recent changes in the blood glucose level.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137868     DOI: 10.1177/000456328201900505

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  2 in total

1.  HbA1 in assessment of metabolic control in diabetic BB/E rats.

Authors:  F J Tames; J D Baird; A J Bone
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

2.  Insulin autoantibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes--a poor predictor of clinical course and antibody response to exogenous insulin.

Authors:  J Karjalainen; M Knip; A Mustonen; H K Akerblom
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.